Skip to content

Researchers grow human astrocytes in situ for the first time for potential ALS cure.

Researchers from the University of Wisconsin have developed a unique model for learning more about the role of human astrocytes.  The findings may lay a foundation for the treatment of a number of neurodegenerative diseases, including ALS (amyotrophic lateral sclerosis) and debilitating spinal cord injuries.  The team state that they expect astrocytes may help neuronal survival and improve disease conditions in ALS and spinal cord injury.  Studies are now ongoing because of these findings.  The current opensource study is published in the Journal of Clinical Investigation.

Astrocytes, so named because of their star shape, are thought to perform a number of important roles in the human brain and spinal cord, and in human health and disease. Animal studies show they are necessary for the development and maintenance of healthy neurons, proper nervous system signaling, and in the formation and maintenance of the crucial blood-brain barrier.  Defects in astrocytic function are associated with ALS and diseases like Rett syndrome, Alexander disease and Huntington’s disease.

The medical community knows very little about human astrocytes, with it commonly being held that they are crucial in human health and disease.  However, studying astrocytes is very difficult.  This is especially true of studying human astrocytes in adults. Previous studies have used newborn mice, which provide a different biological environment for astrocytes, yet at least some of these neurodegenerative diseases, and many spinal cord injuries, occur in human adults.

To overcome this problem the team transplanted immature human nervous system cells, generated from adult stem cells, into the spinal cords of mice. These cells matured into astrocytes.  The researchers checked in from time to time, and within nine months, found the astrocytes had travelled long distances along the mouse spinal cord, hugging the mouse neurons, connecting to blood vessels and joining with one another, just as mouse astrocytes do. They replaced the mouse astrocytes in the process, but did not affect the ability of the mice to function normally.

The team were amazed at this positive outcome.  The researchers suspect that what may actually be happening is the human astrocytes are out-dividing their smaller, mouse counterparts, developing in larger numbers and essentially ‘pushing’ the mouse cells out via natural selection.

The researchers repeated the experiments with astrocytes matured from human patients with ALS. The astrocytes replaced the mouse astrocytes, behaving just like those from nonALS individuals, except they disrupted motor function in the mice, just like in ALS.  The team observed that these mice had problems with movement in their legs and were just beginning to show signs of neuron degeneration.  This showed the researchers that it’s not just a physical replacement, it’s really a functional integration with consequence.

The team now plan to take these findings in the lab to human patients in the clinic.  The team feel that stem cells can be utilized for medical purposes and plan to treat spinal cord injury, and especially ALS.

Source:  Board of Regents of the University of Wisconsin System

Integration of astrocytes from patients with ALS and its effect on mouse MNs.  Integration of astrocytes from patients with ALS and its effect on mouse MNs. Human-derived neural progenitors functionally replace astrocytes in adult mice.  Zhang et al 2015.
Integration of astrocytes from patients with ALS and its effect on mouse MNs. Integration of astrocytes from patients with ALS and its effect on mouse MNs. Human-derived neural progenitors functionally replace astrocytes in adult mice. Zhang et al 2015.

Healthinnovations View All

Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.

Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.

Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.

Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.

Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.

An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.